This video is from the CNS Summit last November.
Post# of 30028
(Total Views: 449)
Posted On: 06/29/2018 3:16:56 PM
This video is from the CNS Summit last November.
I've never seen it before.
I found it interesting that we need $50M to bring Eltoprazine to market.
$37M for Phase 2b, Phase 3 and long term safety study. $2M for NDA application and review. The rest for product launch.
I thought Gerald said we needed around $15M to get to phase 2b data? This says $6M.
We better get going if we want to launch in 2023.
https://vimeo.com/253657890
I've never seen it before.
I found it interesting that we need $50M to bring Eltoprazine to market.
$37M for Phase 2b, Phase 3 and long term safety study. $2M for NDA application and review. The rest for product launch.
I thought Gerald said we needed around $15M to get to phase 2b data? This says $6M.
We better get going if we want to launch in 2023.
https://vimeo.com/253657890
(1)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼